KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model.

KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model.

Item
http://www.wikidata.org/entity/Q34505025
A novel highly potent autotaxin/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tensionSafety and efficacy of silodosin for the treatment of benign prostatic hyperplasiaEffects of castration on contraction and alpha(1)-adrenoceptor expression in rat prostate.α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.Mechanisms Underlying Activation of α₁-Adrenergic Receptor-Induced Trafficking of AQP5 in Rat Parotid Acinar Cells under Isotonic or Hypotonic Conditions.Management of benign prostatic hyperplasia with silodosinTamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity?The Persistence of Silodosin Monotherapy and the Reasons for Withdrawal from Treatment of Previously Untreated Japanese Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.Alpha1A-adrenoceptor antagonist improves underactive bladder associated with diabetic cystopathy via bladder blood flow in rats.Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?Discovery of ONO-7300243 from a Novel Class of Lysophosphatidic Acid Receptor 1 Antagonists: From Hit to Lead.Effects of ρ-Da1a a peptidic α(1) (A) -adrenoceptor antagonist in human isolated prostatic adenoma and anaesthetized rats.Effect of silodosin on specific urinary symptoms associated with benign prostatic hyperplasia: analysis of international prostate symptom scores in 2 phase III clinical studies.Discovery of a Slow Tight Binding LPA1 Antagonist (ONO-0300302) for the Treatment of Benign Prostatic Hyperplasia.Additive effect of oral LDD175 to tamsulosin and finasteride in a benign prostate hyperplasia rat model.
P2860

KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model.

Item
http://www.wikidata.org/entity/Q34505025
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
KMD-3213, a uroselective and l ...... , tested in a novel rat model.
@ast
KMD-3213, a uroselective and l ...... , tested in a novel rat model.
@en
KMD-3213, a uroselective and l ...... , tested in a novel rat model.
@nl
type
label
KMD-3213, a uroselective and l ...... , tested in a novel rat model.
@ast
KMD-3213, a uroselective and l ...... , tested in a novel rat model.
@en
KMD-3213, a uroselective and l ...... , tested in a novel rat model.
@nl
prefLabel
KMD-3213, a uroselective and l ...... , tested in a novel rat model.
@ast
KMD-3213, a uroselective and l ...... , tested in a novel rat model.
@en
KMD-3213, a uroselective and l ...... , tested in a novel rat model.
@nl
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P1433
P1476
KMD-3213, a uroselective and l ...... , tested in a novel rat model.
@en
P2093
P304
P31
P407
P433
P478
P577
P698